Cited by 186Computational Drug Discovery MethodsDomain Adaptation and Few-Shot LearningMachine Learning in Healthcare

Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients

Open access
Ma, Jianzhu, Fong, Samson H., Luo, Yunan, Bakkenist, Christopher J., Shen, John Paul, Mourragui, Soufiane, Wessels, Lodewyk F. A., Hafner, Marc +3 more·2021·Nature Cancer

Abstract

Cell-line screens create expansive datasets for learning predictive markers of drug response, but these models do not readily translate to the clinic with its diverse contexts and limited data. In the present study, we apply a recently developed technique, few-shot machine learning, to train a versatile neural network model in cell lines that can be tuned to new contexts using few additional samples. The model quickly adapts when switching among different tissue types and in moving from cell-line models to clinical contexts, including patient-derived tumor cells and patient-derived xenografts. It can also be interpreted to identify the molecular features most important to a drug response, highlighting critical roles for RB1 and SMAD4 in the response to CDK inhibition and RNF8 and CHD4 in the response to ATM inhibition. The few-shot learning framework provides a bridge from the many samples surveyed in high-throughput screens (n-of-many) to the distinctive contexts of individual patients (n-of-one).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-020-00169-2

Cites

56 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Meta-learning has been applied to learn interactions between cell-line phenotypes with drug responses, and further transferred them into clinical context, enabling prediction on a limited number of human tumor samples.

    “Furthermore, meta-learning has been applied to learn the interactions between cell-line phenotypes with the drug responses, and further transferred them into clinical context, enabling prediction on a limited number of human tumor samples [184].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [44]Meyers RM Computational correction of copy-number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat. Genet 49, 1779– 1784 (2017). 29083409 PMC5709193
  2. [48]Kingma D & Ba J Adam: a method for stochastic optimization. Preprint at arXiv https://arxiv.org/abs/1412.6980 (2014). · arXiv

Cited by

Sorted by citations

Authors
Ma, J., Fong, S. H., Luo, Y., Bakkenist, C. J., Shen, J. P., Mourragui, S., Wessels, L. F. A., Hafner, M., Sharan, R., Peng, J., & Ideker, T.
Affiliations
  • Purdue University West Lafayette (US)
  • University of California San Diego (US)
  • University of Illinois Urbana-Champaign (US)
  • University of Pittsburgh (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • The Netherlands Cancer Institute (NL)
  • Genentech (US)
  • Tel Aviv University (IL)
Corresponding author
Ideker, Trey
Venue
Nature Cancer
Published
2021-01-25
Volume
2
Issue
2
Pages
233-244
ISSN
2662-1347 (ISSN-L)
OpenAlex
W3124481204
Cited by
180
References
56
Citations by year
2026: 27 · 2025: 33 · 2024: 37 · 2023: 37 · 2022: 24 · 2021: 22
FWCI
16.61
Type
journal article
Language
en
Open access
Locations
  • Nature Cancer (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA204173, K22CA234406, U54CA209891)
  • Cancer Prevention and Research Institute of Texas (CPRIT RR180035)
  • ZonMw (40-00812-98-16012)
  • Israel Science Foundation (1652815)
  • National Science Foundation (1652815)
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P41GM103504)
  • U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG009979)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Physical Sciences › Computer Science › Artificial Intelligence › Domain Adaptation and Few-Shot Learning
  • Physical Sciences › Computer Science › Artificial Intelligence › Machine Learning in Healthcare
Keywords
few-shot learning, drug response prediction, patient-derived tumor cells, patient-derived xenografts, RB1, SMAD4, CDK inhibition, RNF8, CHD4, ATM inhibition, high-throughput screening
MeSH terms
Machine Learning, DNA-Binding Proteins, Humans, Neural Networks, Computer, Ubiquitin-Protein Ligases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review